Back to search
FDAFDA · Food and drugs·Recall number D-1323-2020

Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-41

Published June 24, 2020 · Recall initiated: May 28, 2020

Summary

FDA records drug Class II recall D-1323-2020, published June 24, 2020 and initiated May 28, 2020. Recalling firm: Glaxosmithkline Consumer Healthcare Holdings; Status: Terminated; Reported quantity: 151,344 bottles; Lot: Lot #: 8H21C1, Exp 7/31/2020; 9B25C1, Exp 1/31/2021; 9D02C1, Exp 2/28/2021; 9G01C1, Exp 5/31/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

What to do

Voluntary: Firm initiated · Letter

Get an email if GAVISCON has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GAVISCON
Manufacturer
Glaxosmithkline Consumer Healthcare Holdings
Distributor
U.S.A. Nationwide
Lot
Lot #: 8H21C1, Exp 7/31/2020; 9B25C1, Exp 1/31/2021; 9D02C1, Exp 2/28/2021; 9G01C1, Exp 5/31/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-41 recalled?

Yes. FDA published recall D-1323-2020 on June 24, 2020. Reported hazard: Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GAVISCON.